• By ICR Secretariat
  • Posted Thursday, June 30, 2022

Sanofi and GSK report successful efficacy results against Omicron

https://www.pharmatimes.com/news/sanofi_and_gsk_report_successful_efficacy_results_against_omicron_1450497

Sanofi and GSK have announced positive data from their vaccine trial which evaluated an adjuvanted Beta vaccine candidate. This included 75.1% efficacy in previously infected participants.